MADRIGAL PHARMACEUTICALS, INC. - COM (MDGL)

Historical Portfolio Holders from Q2 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
22.6M
Holdings value Q2 2024
$6.34B
Value change Q2 2024
+$531M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
252
Number of buys Q2 2024
152
Number of sells Q2 2024
-115
Average buys Q2 2024 %
+0.002%
Average sells Q2 2024 %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 22.6M $6.34B +$531M $280.16 261
2024 Q1 20.8M $5.54B +$368M $267.04 273
2023 Q4 19.3M $4.46B +$627M $231.38 223
2023 Q3 17M $2.48B +$314M $146.04 207
2023 Q2 14.7M $3.4B +$187M $231.00 206
2023 Q1 13.9M $3.36B +$98.5M $242.26 221
2022 Q4 13.3M $3.86B +$570M $290.25 194
2022 Q3 11.7M $763M -$24.5M $64.99 132
2022 Q2 12M $858M -$22M $71.58 131
2022 Q1 12.2M $1.19B +$32.2M $98.12 133
2021 Q4 11.9M $1.01B +$43.1M $84.74 138
2021 Q3 11M $874M -$37.2M $79.79 129
2021 Q2 11.2M $1.09B -$99.1M $97.41 147
2021 Q1 12.2M $1.43B -$10.2M $116.97 135
2020 Q4 12.3M $1.36B +$68.4M $111.17 132
2020 Q3 11.6M $1.38B +$47.9M $118.73 124
2020 Q2 11.3M $1.27B +$4.83M $113.25 125
2020 Q1 11M $737M +$26.6M $66.76 104
2019 Q4 10.5M $954M +$60.2M $91.11 118
2019 Q3 9.62M $830M -$394K $86.22 107
2019 Q2 9.6M $1.01B +$10.4M $104.81 112
2019 Q1 9.46M $1.18B +$61.3M $125.26 132
2018 Q4 8.98M $1.01B -$6.56M $112.72 130
2018 Q3 8.63M $1.85B +$61.7M $214.13 152
2018 Q2 8.03M $2.24B +$568M $279.69 144
2018 Q1 6.33M $739M +$153M $116.79 98
2017 Q4 5.13M $469M +$233M $91.79 87
2017 Q3 2.67M $120M +$29.2M $44.98 48
2017 Q2 2.04M $33.1M +$8.67M $16.26 37
2017 Q1 1.53M $23.6M +$3.03M $15.40 25
2016 Q4 1.35M $20M +$6.29M $14.90 23
2016 Q3 1.01M $12.8M +$12.7M $12.68 25
2016 Q2 79.6K $21K +$21K $0.26 1